We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Annual Mammogram Proves Most Effective to Prevent Cancer

By MedImaging International staff writers
Posted on 29 Aug 2017
Print article
Researchers comparing breast cancer screening recommendations have found that annual screening starting from age 40 would reduce breast cancer-specific deaths by the highest percentage.

The researchers used computer models to investigate the effectiveness of three annual screening strategies that were also programmed to look for risks related to screening such as callbacks for more imaging scans, or a needle biopsy to find false positive results.

The study was led by researchers from Weill Cornell Medicine (New York, NY, USA), New York-Presbyterian (New York, NY, USA), and the University of Colorado School of Medicine (Aurora, CO, USA), and was published in the August 21, 2017, issue of the journal Cancer. The goal of the study was intended to uncover insights to help women make the best choices for mammography screening.

The first screening strategy consisted of screening from age 40 years; the second consisted of annual screening beginning at ages of 45 to 54 years, with additional biennial screening for 55 to 79 year olds. The third strategy consisted only of biennial screening for 50 to 74 year olds. The results showed that screening beginning at age 40 reduced breast cancer-specific deaths by nearly 40%, while the other recommendations reduced deaths from the disease by between 23% and 31%.

Elizabeth Kagan Arleo, MD, Weill Cornell Medicine, and New York-Presbyterian, said, "Our findings are important and novel because this is the first time the three most widely discussed recommendations for screening mammography have been compared head to head. Our research would be put to good use if, because of our findings, women chose to start annual screening mammography starting at age 40. Over the long term, this would be significant because fewer women would die from breast cancer."

Related Links:
Weill Cornell Medicine
New York-Presbyterian
University of Colorado School of Medicine
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Area Product Meter
VacuDAP
New
X-Ray Detector
FDR-D-EVO III
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.